Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy
暂无分享,去创建一个
R. David | D. Clevert | K. Klingel | M. Sauter | R. Kandolf | Markus P. Vallaster | W. Franz | C. Rimmbach | H. Theiss | U. Grabmaier | S. Brunner | B. Huber | J. Grabmeier | M. Leiss
[1] M. Ashraf,et al. Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart , 2012, Basic Research in Cardiology.
[2] T. Thum,et al. Epigenetic modifications in cardiovascular disease , 2012, Basic Research in Cardiology.
[3] C. Rischpler,et al. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis. , 2011, Stem cell research.
[4] R. Bolli,et al. Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond , 2011, Basic Research in Cardiology.
[5] N. Zhang,et al. Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation , 2011, Basic Research in Cardiology.
[6] M. Reiser,et al. Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)--rationale, design and first interim analysis. , 2010, International journal of cardiology.
[7] M. Fujita,et al. Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide. , 2010, Journal of molecular and cellular cardiology.
[8] M. Schieber,et al. Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance , 2010, Circulation.
[9] S. Hazen,et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation , 2010, Nature Medicine.
[10] S. Leschka,et al. Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis--ongoing inflammation and an imbalance of the matrix degrading system. , 2010, European journal of pharmacology.
[11] W. Franz,et al. Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy , 2010, Expert opinion on biological therapy.
[12] Teruo Okano,et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. , 2009, The Journal of clinical investigation.
[13] Robert David,et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. , 2009, Cell stem cell.
[14] B. Maron,et al. Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2009, Circulation.
[15] W. Franz,et al. Stem cell mobilisation for myocardial repair , 2008 .
[16] R. David,et al. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells. , 2008, Experimental hematology.
[17] J. Kastrup,et al. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. , 2008, Journal of the American College of Cardiology.
[18] F. Schmidt. Meta-Analysis , 2008 .
[19] Klaus Schotten,et al. Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). , 2007, European heart journal.
[20] A. Weinzierl,et al. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. , 2006, American Journal of Pathology.
[21] I. Hoefer,et al. G-csf Administration after Myocardial Infarction in Mice Attenuates Late Ischemic Cardiomyopathy by Enhanced Arteriogenesis , 2022 .
[22] D. Stupack,et al. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. , 2006, The Journal of clinical investigation.
[23] I. Komuro,et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes , 2005, Nature Medicine.
[24] L. Akard,et al. Transplantation of hematopoietic stem cells from the peripheral blood , 2005, Journal of cellular and molecular medicine.
[25] K. Klingel,et al. Molecular pathology of inflammatory cardiomyopathy , 2004, Medical Microbiology and Immunology.
[26] J. Mason. Myocarditis and dilated cardiomyopathy: an inflammatory link. , 2003, Cardiovascular research.
[27] C. Heeschen,et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells , 2003, Nature Medicine.
[28] Eric J Topol,et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy , 2003, The Lancet.
[29] Federica Limana,et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Homma,et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.
[31] J. Schaper,et al. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. , 1997, European heart journal.
[32] Y. Yazaki,et al. EXPRESSION OF VASCULAR CELL ADHESION MOLECULE‐1 IN MURINE HEARTS WITH ACUTE MYOCARDITIS CAUSED BY COXSACKIEVIRUS B3 , 1996, The Journal of pathology.
[33] C. Kishimoto,et al. Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice. , 1995, European heart journal.
[34] A. Koch,et al. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 , 1995, Nature.
[35] M. Labow,et al. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. , 1995, Development.
[36] R. Hynes,et al. Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. , 1995, Development.
[37] S. Huber. VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells , 1994, Journal of virology.
[38] P. Hofschneider,et al. Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[39] Ground Ke,et al. Occurrence and significance of myocarditis in trauma. , 1970 .
[40] A. Angelini,et al. Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy , 2012, Basic Research in Cardiology.
[41] K. Klingel,et al. Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis , 2007, Journal of Molecular Medicine.
[42] K. Klingel,et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.